ZENOTECH LABORATORIES
|
ZENOTECH LABORATORIES Last 5 Year Financial Ratios History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -0.18 | 0.92 | 1.36 | 1.90 | 3.63 |
| CEPS(Rs) | 0.99 | 2.06 | 2.52 | 3.07 | 4.78 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 15.59 | 15.75 | 14.84 | 13.48 | 11.57 |
| Tax Rate(%) | 125.59 | 47.50 | 25.51 | 20.11 | -123.97 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 21.07 | 32.94 | 42.16 | 48.80 | 47.75 |
| EBIT Margin(%) | 9.60 | 24.84 | 27.29 | 34.45 | 30.40 |
| Pre Tax Margin(%) | 9.60 | 24.84 | 27.29 | 34.18 | 27.08 |
| PAT Margin (%) | -2.46 | 13.04 | 20.32 | 27.31 | 60.65 |
| Cash Profit Margin (%) | 13.85 | 29.21 | 37.68 | 44.22 | 79.72 |
| Performance Ratios | |||||
| ROA(%) | -0.98 | 5.43 | 8.68 | 13.37 | 26.45 |
| ROE(%) | -1.12 | 6.01 | 9.60 | 15.15 | 37.26 |
| ROCE(%) | 4.38 | 11.46 | 12.89 | 18.39 | 15.26 |
| Asset Turnover(x) | 0.40 | 0.42 | 0.43 | 0.49 | 0.44 |
| Sales/Fixed Asset(x) | 0.36 | 0.37 | 0.37 | 0.40 | 0.35 |
| Working Capital/Sales(x) | 1.50 | 1.84 | 3.23 | -123.98 | -4.46 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.76 | 2.68 | 2.70 | 2.50 | 2.83 |
| Receivable days | 67.92 | 45.38 | 29.38 | 31.20 | 38.59 |
| Inventory Days | - | - | 7.51 | - | 0.61 |
| Payable days | - | 1,263.19 | - | - | - |
| Valuation Parameters | |||||
| PER(x) | - | 56.45 | 43.47 | 24.79 | 13.86 |
| PCE(x) | 34.64 | 25.20 | 23.45 | 15.31 | 10.54 |
| Price/Book(x) | 2.20 | 3.30 | 3.98 | 3.49 | 4.35 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 4.10 | 6.74 | 8.35 | 6.51 | 8.50 |
| EV/Core EBITDA(x) | 15.56 | 18.45 | 18.71 | 12.67 | 17.18 |
| EV/EBIT(x) | 42.70 | 27.14 | 30.61 | 18.89 | 27.97 |
| EV/CE(x) | 1.88 | 3.02 | 3.77 | 3.36 | 3.80 |
| M Cap / Sales | 4.80 | 7.36 | 8.83 | 6.77 | 8.40 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 1.32 | 5.42 | -3.75 | 16.02 | 62.91 |
| Core EBITDA Growth(%) | -26.90 | -13.70 | -16.34 | 20.44 | 166.48 |
| EBIT Growth(%) | -60.82 | -4.03 | -23.76 | 31.47 | 3,244.31 |
| PAT Growth(%) | -119.10 | -32.36 | -28.37 | -47.76 | 1,925.03 |
| EPS Growth(%) | -119.10 | -32.36 | -28.37 | -47.76 | 1,925.01 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | 0.08 |
| Current Ratio(x) | 3.40 | 2.86 | 1.93 | 0.98 | 0.47 |
| Quick Ratio(x) | 3.40 | 2.86 | 1.87 | 0.98 | 0.47 |
| Interest Cover(x) | - | - | - | 130.25 | 9.15 |
| Total Debt/Mcap(x) | - | - | - | - | 0.02 |
Compare Financial Ratios of peers of ZENOTECH LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZENOTECH LABORATORIES | ₹281.6 Cr | -1.1% | -1.2% | -23.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,815.0 Cr | 0.5% | 6.2% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹192,678.0 Cr | 4.7% | 9% | 7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,323.0 Cr | -3.7% | 7.2% | 49.8% | Stock Analytics | |
| CIPLA | ₹114,585.0 Cr | -0.6% | 5% | -3.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,067.0 Cr | -1.9% | -4.6% | -2.8% | Stock Analytics | |
ZENOTECH LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZENOTECH LABORATORIES | -1.1% |
-1.2% |
-23.8% |
| SENSEX | 0.8% |
1.8% |
-6.5% |
You may also like the below Video Courses
